Navigation Links
Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update
Date:5/3/2011

www.anthera.com/">www.anthera.com.

Safe Harbor Statement

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These include, but are not limited to, statements relating to the anticipated initiation of Anthera's clinical studies, anticipated duration and expected results of these studies, and the progression of Anthera's products through future stages of clinical development. These forward-looking statements are based on Anthera's expectations as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially as set forth in the Company's public filings with the Securities and Exchange Commission, including Anthera's Annual Report on Form 10-K for the year ended December 31, 2010. Anthera disclaims any intent or obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law.

CONTACT: Bianca Nery of Anthera Pharmaceuticals, Inc., bnery@anthera.com or 510-856-5586.ANTHERA PHARMACEUTICALS, INC.A Development Stage CompanySTATEMENT OF OPERATIONS(unaudited)Three Months Ended March 31,20112010OPERATING EXPENSE:Research and development

$
,316,758$
5,241,814General and administrative

2,339,8821,224,110Total operating expense

18,656,6406,465,924LOSS FROM OPERATIONS:

(18,656,640)(6,465,924)OTHER INCOME (EXPENSE):Other expense and interest income, net

90,935(4,637,868)Total other income (expense)

90,935(4,637,868)NET LOSS

$  (18,565,705)$  (11,103,792)Net loss per share--basic and diluted

$
(0.56)$
(0.83)Weighted-average number of shares used in
per share calculatio
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Pharmaceuticals Successfully Completes Interim Biomarker Analysis of VISTA-16 Study and Third Safety Review of Varespladib Methyl
2. Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
3. Anthera Pharmaceuticals Names Lawrence Rosania as Vice President of Global Regulatory Affairs and Compliance
4. Dr. Peter Thompson Joins Anthera Pharmaceuticals Board of Directors
5. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
6. Anthera Announces Update Call Regarding Vial Problems
7. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
8. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
9. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing
10. Anthera Pharmaceuticals to Present at Deutsche Bank Securities 35th Annual Health Care Conference
11. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 ... prospects for leading ophthalmic drug companies  What ... pharma ophthalmic industry ? Visiongain,s brand new report ... opportunities and prospects there. Our 242-page report ... lucrative areas in the industry and the future market ...
(Date:3/27/2015)... 27, 2015 The International Myeloma Foundation (IMF) ... while working toward prevention and a cure – today ... a federal resolution (H. Res. 174) that supports the ... Multiple Myeloma Awareness Month." Currently there are ... more than 110,000 new cases are diagnosed yearly, according ...
(Date:3/27/2015)... March 27, 2015 RnRMarketResearch.com ... therapeutic market research report of 52 pages with ... business intelligence library. The report "Visceral ... the therapeutic development for Visceral Pain, complete with ... drug target, mechanism of action (MoA), route of ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4
... Nov. 9 New data from the JUPITER,study ... major cardiovascular (CV) events (defined in this,study as ... hospitalization for unstable angina, or death from CV,causes) ... among men and women,with elevated hsCRP but low ...
... 7 Data from an investigational,open-label, randomized ... alfa) in treating anemia in subjects with ... were presented today at the American Society,of ... dosing groups, including the FDA-approved,three-times-per-week (TIW) regimen, ...
Cached Medicine Technology:CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 2CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 3CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 4CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study 5Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 2Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 3Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 4Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 5Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 6
(Date:3/28/2015)... 2015 Genomic medicine experts have sequenced ... for the first time, key information for understanding and ... the newly posted story on the Surviving Mesothelioma ... British Columbia, the British Columbia Cancer Agency, and PhenoPath ... underlying molecular alterations and mutations that can lead to ...
(Date:3/28/2015)... Portland, OR (PRWEB) March 28, 2015 ... in the media regarding recent changes and proposals around ... TV , current and former collegiate student-athletes across a ... experiences and reflect on common challenges. The special panel ... the country in sports ranging from football, track and ...
(Date:3/28/2015)... Healthpointe’s otolaryngologists, medical practitioners who attend ... disorders, are now offering a wide variety of treatments ... characterized by the presence of phantom sounds or ringing ... is a prevalent symptom that can arise due to ... tinnitus can impede a person’s quality of life. , ...
(Date:3/28/2015)... Viejo, California (PRWEB) March 28, 2015 ... announced a new overlay entitled Scratches 5K from Pixel ... grungy scratch effects to any media inside Final Cut ... Studios. “StoryBoard Corporate saves time and is an effective ... media using FCPX Overlay Scratches 5K's intuitive grunge overlays. ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Purity ... dietary supplements announces the release of their revolutionary ... shown in two randomized, double-blind, placebo-controlled clinical studies ... waist and hip size. MuffinStop™ is a combination ... and Garcinia mangostana, fused together to create one ...
Breaking Medicine News(10 mins):Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2
... medicines will no longer be available to Canadians from supermarkets ... are aimed at preventing addicts from making crystal meth. //The ... be affected by the ban which will come into force ... sell about 15 medicines which are of the single ingredient ...
... might soon have a vaccine to combat a disease (cervical ... Merck had submitted details of a cervical cancer vaccine, // ... types of infection with the human papilloma virus (HPV) to ... ,Another vaccine, developed by GlaxoSmithKline wound soon be approved for ...
... Medical Sciences has revealed that early stroke and dementia maybe due ... Incidences of blood pressure at an early age should not be ... a lesser blood flow to it due to hypertension, thus raising ... ,This has been confirmed in as many as 33% ...
... rate of intentional injury. This includes cases like suicide and ... a mental health advocate blames the mental health service or ... higher than that seen in Adelaide. He is calling ... kindly donate money to improve the child and adolescent health ...
... Department of Health Services would be banning Mexican candies with ... high levels of lead// in Mexican candies the Officials ... high amount of lead. It is known that there are ... Government is planning to have stringent quality check testing of ...
... treatment for cancer is a drug or substance that stops ... obliterating// or stopping cancer to spread. ,With the same ... report that a compound related to vitamin A is useful ... preventing or slowing tumour growth in mice prone to lung ...
Cached Medicine News:Health News:Cervical Cancer Vaccine Show Promise In Prevention 2Health News:A treatment for lung cancer: similar to Vitamin A but with few side effects. 2
No. 1. 30 mm conventional blades. Thin well-rounded tips....
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Shaft angled 45 degrees. Manufactured in titanium....
Solid 13.5 mm wide by 5 mm deep blades. Edge of blades serrated. Dull finish....
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Medicine Products: